US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Manufacturing, Packaging & Detailing Market Research Reports & Industry Analysis

RSS Feeds

Manufacturing, Packaging & Detailing Industry Research & Market Reports

3  4  5  6    8    10  11  12  
Ghana Pharmaceuticals and Healthcare Report Q2 2015
4/15/2015 | published by: BMI Research
... to a lack of payments. Furthermore, we believe that the scheme will come under even morescrutiny in light of the proposed government spending revision on the back of lower oil prices. Headline Expenditure Projections Pharmaceuticals: ...  |  read more...
USD 1,295
Denmark Pharmaceuticals and Healthcare Report Q2 2015
4/22/2015 | published by: BMI Research
... not expecting to follow suit until 2016. In the longer term, Denmark's aging population will have anunprecedented effect on the market with an older generation driving medicine and healthcare expenditure. However, in-line with many other ...  |  read more...
USD 1,295
Portugal Pharmaceuticals and Healthcare Report Q2 2015
4/22/2015 | published by: BMI Research
... partners, posesupside risk to Portugal's pharmaceuticals and healthcare sector growth forecasts over a multi-quarterhorizon. However, given the government's emphasis on pharmaceuticals spending control, we expect thedrug market negative growth to gradually moderate before entering positive ...  |  read more...
USD 1,295
United Arab Emirates Pharmaceuticals and Healthcare Report Q2 2015
4/22/2015 | published by: BMI Research
... increasing volume of sales will offset losses frompharmaceutical companies and we have maintained our positive market forecast. Increased affordabilitylevels among the population, compulsory health insurance and medical tourism are all key drivers ofgrowth in the ...  |  read more...
USD 1,295
Vietnam Pharmaceuticals and Healthcare Report Q2 2015
4/22/2015 | published by: BMI Research
... regional variations in healthcare infrastructure, including a concentration of doctorsand hospital facilities in the urban provinces of the country. Headline Expenditure Projections Pharmaceuticals: VND80,731bn (USD3.81bn) in 2014 to VND92,719bn (USD4.32bn) in 2015; +14.8%in local currency ...  |  read more...
USD 1,295
Australia Pharmaceuticals and Healthcare Report Q3 2015
4/29/2015 | published by: BMI Research
... the government to place pressure on pharmaceutical expenditure. Patented drugs willcontinue to account for the majority of the pharmaceuticals market share in Australia, with this share toonly slightly moderate over the next years. In fact, ...  |  read more...
USD 1,295
Croatia Pharmaceuticals and Healthcare Report Q3 2015
4/29/2015 | published by: BMI Research
... make painful cuts. We expect this to hurt pharmaceutical expenditure as pricerestrictions are enacted. We expect growth in pharmaceutical sales to remain depressed over the shortterm, with serious implications towards Croatia's attractiveness to pharmaceutical companies. ...  |  read more...
USD 1,295
Gabon Pharmaceuticals and Healthcare Report Q3 2015
4/29/2015 | published by: BMI Research
... very basic, with manufacturers unable to supply the demands of thepopulation. Headline Expenditure Forecasts Pharmaceuticals: XAF50.94bn (USD104mn) in 2014 to XAF54.14bn (USD91mn) in 2015; +6.3% inlocal currency and -12.7% in US dollar terms. Forecast unchanged ...  |  read more...
USD 1,295
Mexico Pharmaceuticals and Healthcare Report Q3 2015
4/29/2015 | published by: BMI Research
... next 10 years tobecome the largest proportion of total pharmaceutical spending. The government's increased focus on anticounterfeitmedicine measures will improve the country's appeal to foreign drugmakers over the long term. Headline Expenditure Projections Pharmaceuticals: MXN184.9bn ...  |  read more...
USD 1,295
New Zealand Pharmaceuticals and Healthcare Report Q3 2015
4/29/2015 | published by: BMI Research
... generics and biosimilars will be hampered by the branded drug bias of an aging populationwho demand access to rising volumes of innovative pharmaceuticals. However, the conversion of theseconditions into growth for drugmakers will increasingly be ...  |  read more...
USD 1,295
Argentina Pharmaceuticals and Healthcare Report Q3 2015
5/6/2015 | published by: BMI Research
... in LatinAmerica. Combined with expected improvements in the Argentinean business environment to take placewith the next government administration since 2016, risks to our pharmaceuticals and healthcare forecastsare weighted to the upside. However, we expect a ...  |  read more...
USD 1,295
Cote d'Ivoire Pharmaceuticals and Healthcare Report Q3 2015
5/6/2015 | published by: BMI Research
... the total healthcare market over the long term. More hospitals and clinics will be opened,increasing access to medical services. Headline Expenditure Projections Pharmaceuticals: XOF232.5bn (USD475mn) in 2014 to XOF250.1bn (USD420mn) in 2015; +7.6% inlocal currency ...  |  read more...
USD 1,295
Slovenia Pharmaceuticals and Healthcare Report Q3 2015
5/6/2015 | published by: BMI Research
... in Slovenia will push demand for pharmaceutical imports. The Slovenian pharmaceutical industry'sfocus on generic drugs will be beneficial given the developing trend for greater generic penetration inEurope and the demand for low-cost medicines in emerging ...  |  read more...
USD 1,295
Thailand Pharmaceuticals and Healthcare Report Q3 2015
5/6/2015 | published by: BMI Research
... country'smedical tourism industry. This will provide significant revenue earning opportunities for private healthcareproviders, innovative drugmakers and medical device companies. Headline Expenditure Projections Pharmaceuticals: THB145.5bn (USD4.5bn) in 2014 to THB152.9bn (USD4.7bn) in 2015; +5.1% inlocal currency ...  |  read more...
USD 1,295
Austria Pharmaceuticals and Healthcare Report Q3 2015
5/13/2015 | published by: BMI Research
... growth expectations remain resiliently subdued over the next few years, which prompted us tomake downward revisions and caused a decline in Risk/Reward Index. Headline Expenditure Projections Pharmaceuticals: EUR4.45bn (USD5.96bn) in 2014 to EUR4.42bn (USD4.86bn) in ...  |  read more...
USD 1,295
Colombia Pharmaceuticals and Healthcare Report Q3 2015
5/13/2015 | published by: BMI Research
... the healthcareand pharmaceutical markets on positive trajectories. However, the country's expanding counterfeit drugmarket along with government bailouts for local health insurance schemes will remain a risk in 2015. Headline Expenditure Projections Pharmaceuticals: COP8,643bn (USD4.3bn) in ...  |  read more...
USD 1,295
Hungary Pharmaceuticals and Healthcare Report Q3 2015
5/13/2015 | published by: BMI Research
... pharmaceutical sales over the short-term. Consumer demand for over-the-countermedicines and greater uptake of generic medicines will be the primary drivers of pharmaceutical salesgrowth, as uptake of innovative drugs will remain hindered by the pricing sensitivity ...  |  read more...
USD 1,295
Japan Pharmaceuticals and Healthcare Report Q3 2015
5/13/2015 | published by: BMI Research
... morecompetitive environment for innovative medicines. In addition, top line growth for foreign-basedmultinational drugmakers will be further challenged by the depreciation of the yen, which will remain weakunder the country's 'Abenomics' economic initiative. Headline Expenditure Projections ...  |  read more...
USD 1,295
Poland Pharmaceuticals and Healthcare Report Q3 2015
5/13/2015 | published by: BMI Research
... given their current focus onbudgetary restraint. Over the longer term, we expect these budgetary restrictions to ease and healthcarespending to accelerate, given our positive economic outlook for Poland. In light of our expectations, Polandwill become ...  |  read more...
USD 1,295
Tanzania Pharmaceuticals and Healthcare Report Q3 2015
5/13/2015 | published by: BMI Research
... fromthose employed in the informal and agriculture sectors will be less likely, limiting its uptake. Headline Expenditure Projections Pharmaceuticals: TZS797bn (USD479mn) in 2014 to an expected TZS909bn (USD496mn) in 2015;+14.0% growth in local currency terms ...  |  read more...
USD 1,295
Cameroon Pharmaceuticals and Healthcare Report Q3 2015
5/20/2015 | published by: BMI Research
... of the industry will continue to bediamond mining with continued investment, both domestic and international, in this segment helping tosupport steady growth in output over our forecast period. While the Angolan government is increasinglyturning its ...  |  read more...
USD 1,295
The 2016 Report on Antacid Pharmaceutical Preparations Excluding Effervescent Salicylate Analgesics: World Market Segmentation by City
4/30/2015 | published by: Icon Group International, Inc.
... markets. With the advent of a “borderless world”, cities become a more important criteria in prioritizing markets, as opposed to regions, continents, or countries. This report covers the top 2000 cities in over 200 countries. ...  |  read more...
USD 995
Antibacterial Drugs: World Industry And Market Prospects 2015-2025
5/1/2015 | published by: Visiongain
... new revenue predictions, also exploring research and development. Those drugs hold high selling potentials. There you assess results, progress, therapies and opportunities. Visiongain’s new report forecasts those revenues to 2025 at overall world market, submarket, ...  |  read more...
USD 2,788
Global Orphan Diseases Partnering 2010-2015: Deal trends, players and financials
5/1/2015 | published by: Current Partnering
... worlds leading healthcare companies. Trends in orphan diseases partnering deals Disclosed headlines, upfronts, milestones and royalties by stage of development Orphan diseases partnering contract documents Top orphan diseases deals by value The Global Orphan Diseases ...  |  read more...
USD 1,995
Global and Chinese TROLEANDOMYCIN (CAS 311074) Industry, 2015 Market Research Report
4/17/2015 | published by: Prof-Research
... key statistics on the market status of the TROLEANDOMYCIN manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Firstly, the report provides a basic overview of ...  |  read more...
USD 3,000
3  4  5  6    8    10  11  12